Georgia Regents Medical Center Selects Equashield's Drug Delivery Safety Solution - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Georgia Regents Medical Center Selects Equashield's Drug Delivery Safety Solution Equashield's Closed System Will Provide Medical Professionals with Unprecedented Protection while Compounding and Administering Hazardous Drugs


Georgia Regents Medical Center Selects Equashield's Drug Delivery Safety Solution

Equashield's Closed System Will Provide Medical Professionals with Unprecedented Protection while Compounding and Administering Hazardous Drugs

PR Newswire

AUGUSTA, Georgia and PORT WASHINGTON, New York, January 27, 2014 /PRNewswire/ --

Equashield (http://www.equashield.com), the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, and the Georgia Regents Medical Center (http://www.grhealth.org), a world-class academic medical center located in Augusta, Georgia, today announced that Equashield's solutions will be used in both the Medical Center and the Cancer Center Pharmacy to reduce hazardous drug exposure.

"We are deeply committed to the safety and well-being of our patients and expert medical staff, and are pleased to introduce Equashield into our facilities," said Kevin Corbin, Pharmacy Manager at Georgia Regents Medical Center. "When searching for a closed system solution, we were impressed with the high-level of protection that Equashield offers, and its ease of use."

Studies have linked exposure to hazardous drugs, including potent chemotherapy medications, to an increase in the risk of adverse health effects in medical professionals. Exposure occurs not only through contact with drug residue on syringes and work surfaces, but also through, contact with aerosols and vapor while preparing and administering such drugs.

"We are pleased to see institutions like the Georgia Regents Medical Center taking a proactive approach to the safety of the staff that works with these hazardous drugs on a daily basis," said Chris McFarlane, Sales Manager at Equashield. "We are proud to have been selected by the Georgia Regents Medical Center and look forward to supplying them with this important new layer of protection."

About Equashield

Equashield is a provider of the world's safest Closed System Transfer Devices (CSTD), clinically proven to protect healthcare professionals from hazardous drug and vapor exposure. The company's flagship device, EQUASHIELD® II, is the fastest CSTD to deploy and easiest to use.  It is also the only truly closed device on the market, covering more routes of exposure than alternative systems and protecting against exposure to hazardous drug residue on contaminated syringe plungers. For more information, visit the company's website at http://www.equashield.com. Follow Equashield on Twitter: @equashield.

About Georgia Regents Medical Center

Georgia Regents Medical Center is a not-for-profit corporation in Augusta, Ga.,that provides clinical operations as a cooperative organization for Georgia Regents University. The 478-bed Medical Center includes a Critical Care Center, housing the region's only Level I trauma center ; the 154-bed Children's Hospital of Georgia, providing the highest level of pediatric critical care and neonatal intensive care; and more than 80 outpatient clinics that provide primary and specialty care. Georgia Regents physicians are consistently ranked among the nation's best in both America's Top Doctors® and Best Doctors in America®. http://www.grhealth.org/

Media Contacts:
Finn Partners Israel for Equashield
Ellie Hanson
ellie@finnpartners.co.il
+972-54-467-6980

Denise Parrish for GRMC
mparrish@gru.edu
+1-706-721-9566

SOURCE Equashield

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
88%
Borrow lightly from EMA's pathway program?
4%
Create entirely its own pathway program?
8%
View Results
Untitled Document

Click here